Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 5, 2022
[NTD Drug Discovery Booster, Achievements and Next Steps]Tatsuro Kuzuki, Benjamin Perry, Charles MowbrayVaccines|October 26, 2024
Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous LeishmaniasisAndrea Lafleur, Stephane Daffis, Charles Mowbray, et al.Expert Review of Anti-Infective Therapy|September 11, 2014
Treatment options for second-stage gambiense human African trypanosomiasisGilles Eperon, Manica Balasegaram, Julien Potet, et al.Bioorganic & Medicinal Chemistry Letters|September 23, 2008
Small, non-peptide C5a receptor antagonists: part 2Julian Blagg, Charles Mowbray, David Pryde, et al.Bioorganic & Medicinal Chemistry Letters|September 24, 2008
Small, non-peptide C5a receptor antagonists: part 1Julian Blagg, Charles Mowbray, David C Pryde, et al.Antimicrobial Agents and Chemotherapy|July 3, 2019
Pharmacokinetics and Pharmacodynamics of the Nitroimidazole DNDI-0690 in Mouse Models of Cutaneous LeishmaniasisGert-Jan Wijnant, Simon L Croft, Raul de la Flor, et al.PLOS Global Public Health|July 9, 2024
Correction: Facing the escalating burden of dengue: Challenges and perspectivesGathsaurie Neelika Malavige, Peter Sjö, Kavita Singh, et al.PLOS Global Public Health|December 15, 2023
Facing the escalating burden of dengue: Challenges and perspectivesGathsaurie Neelika Malavige, Peter Sjö, Kavita Singh, et al.Biorxiv : the Preprint Server for Biology|July 3, 2023
Combinatorial Regimens Augment Drug Monotherapy for SARS-CoV-2 Clearance in MiceIrfan Ullah, Fanny Escudie, Ivan Scandale, et al.Iscience|February 16, 2024
Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimensIrfan Ullah, Fanny Escudie, Ivan Scandale, et al.Pageof 2